2.12
Okyo Pharma Limited (OKYO) 最新ニュース
H.C. Wainwright reiterates Buy rating on OKYO Pharma stock at $7 target - Investing.com
OKYO Pharma appoints Robert Dempsey as new CEO By Investing.com - Investing.com Nigeria
OKYO Pharma: Strengthened Leadership and Promising Urcosimod Data Support Reiterated Buy Rating and Upside Potential - TipRanks
OKYO Pharma appoints Ophthalmology veteran Robert Dempsey as new CEO - Proactive financial news
OKYO Pharma names ophthalmology veteran Robert Dempsey as CEO - Proactive financial news
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer - BioSpace
OKYO Pharma names Robert J. Dempsey as chief executive officer By Investing.com - Investing.com Australia
OKYO Pharma names Robert J. Dempsey as chief executive officer - Investing.com
OKYO Pharma Names Ophthalmology Veteran Robert J. Dempsey as CEO to Drive Next Growth Phase - TipRanks
Is Alico Inc stock a smart buy before Fed meetingRisk Management & Fast Exit and Entry Trade Guides - moha.gov.vn
Will OKYO Pharma Limited stock remain a Wall Street favoriteTrendline Breakouts & Free High Yield Portfolio Picks - bollywoodhelpline.com
H.C. Wainwright reiterates Buy rating on OKYO Pharma stock at $7 target By Investing.com - Investing.com India
Technical Analysis: What dividend safety score for OKYO Pharma Limited stockMarket Activity Recap & Fast Moving Stock Trade Plans - moha.gov.vn
OKYO Pharma reports positive phase 2 results for Urcosimod in neuropathic corneal pain - MSN
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Short Interest Update - MarketBeat
Will OKYO Pharma Limited stock maintain dividend yieldJuly 2025 Catalysts & Trade Opportunity Analysis Reports - Улправда
Volatility Watch: How OKYO Pharma Limited OK11 stock gains from tech spendingJuly 2025 Price Swings & Verified High Yield Trade Plans - moha.gov.vn
Bank Watch: What Wall Street predicts for OKYO Pharma Limited stock priceJuly 2025 Levels & Daily Chart Pattern Signals - Улправда
Will OKYO Pharma Limited (OK11) stock hit analyst forecastsMarket Trend Review & Weekly High Return Stock Opportunities - Улправда
Is OKYO Pharma Limited stock affected by interest rate hikesTake Profit & AI Powered Market Trend Analysis - Улправда
Will OKYO Pharma Limited stock see PE expansionJuly 2025 Reactions & Stock Market Timing Techniques - Улправда
Small cap wrap: Gunnison Copper, OKYO Pharma, Abacus Global Management… - Proactive Investors
Is OKYO Pharma Limited (OK11) stock suitable for passive index fundsJuly 2025 EndofMonth & Weekly High Return Stock Forecasts - Улправда
OKYO Pharma management to ring Nasdaq opening bell in New York - Investing.com Australia
Pullback Watch: Why retail investors pile into OKYO Pharma Limited stock2025 Market WrapUp & AI Driven Stock Movement Reports - DonanımHaber
OKYO Pharma Ltd Rings the Nasdaq Stock Market Opening Bell - Nasdaq
OKYO Pharma Ltd Rings the Opening Bell - Nasdaq
OKYO Pharma has dry eyes as a lucrative prize in its sights - Proactive Investors
OKYO Pharma management to ring Nasdaq opening bell in New York By Investing.com - Investing.com South Africa
OKYO Pharma Rings Nasdaq Opening Bell as Urcosimod Advances After Positive Phase 2 NCP Data - TipRanks
Will OKYO Pharma Limited stock outperform growth indexesPortfolio Risk Report & High Conviction Trade Alerts - DonanımHaber
OKYO Pharma to Ring the Opening Bell at Nasdaq - The Manila Times
How OKYO Pharma Limited (OK11) stock gains from tech spendingMarket Performance Summary & Expert Verified Stock Movement Alerts - DonanımHaber
Why OKYO Pharma Limited stock is rated strong buy2025 Growth vs Value & Comprehensive Market Scan Insights - DonanımHaber
Is OKYO Pharma Limited stock trading at a premium valuationPortfolio Risk Summary & Detailed Earnings Play Alerts - Улправда
Will OKYO Pharma Limited stock deliver long term returnsBreakout Watch & High Conviction Investment Ideas - Улправда
Is OKYO Pharma Limited stock positioned for digital transformation2025 Retail Activity & Precise Swing Trade Alerts - Улправда
OKYO Pharma reports favorable phase 2 data for NCP asset - Eyes On Eyecare
Okyo Pharma executive chairman increases stake in company By Investing.com - Investing.com Australia
Okyo Pharma executive chairman increases stake in company - Investing.com India
Okyo Pharma chairman acquires 24,551 company shares - TipRanks
Panetta Partners increases stake in OKYO Pharma with new share purchase - Investing.com Canada
Check out OKYO Pharma Ltd's stock price (OKYO) in real time - CNBC
Panetta Partners increases stake in OKYO Pharma with new share purchase By Investing.com - Investing.com South Africa
OKYO Pharma Chairman Increases Stake Amid Promising Drug Trials - TipRanks
OKYO Pharma Announces Chairman and Founder Acquires Shares - The Manila Times
大文字化:
|
ボリューム (24 時間):